Immatics (IMTX) CEO reports options, RSUs and share holdings

Rhea-AI Filing Summary

Immatics N.V. director and Chief Executive Officer Harpreet Singh Jasuja filed an initial ownership report showing a mix of ordinary shares, stock options and restricted stock units. He directly holds 217,241 ordinary shares and multiple option grants over ordinary shares with exercise prices ranging from $1.06 to $11.00, plus 167,500 RSUs that each convert into one ordinary share as they vest over time.

SEC Form 3

FORM 3

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0104
Estimated average burden
hours per response:			0.5

1. Name and Address of Reporting Person^*

Singh Jasuja Harpreet

(Last) (First) (Middle)

PAUL-EHRLICH-STR. 15

(Street)

TUBINGEN 72076

(City) (State) (Zip)

GERMANY

(Country)

2. Date of Event Requiring Statement (Month/Day/Year)
03/18/2026

3. Issuer Name and Ticker or Trading Symbol
Immatics N.V. [ IMTX ]

3a. Foreign Trading Symbol

5. If Amendment, Date of Original Filed (Month/Day/Year)

4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Chief Executive Officer

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4)	2. Amount of Securities Beneficially Owned (Instr. 4)	3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	4. Nature of Indirect Beneficial Ownership (Instr. 5)
Ordinary Shares	217,241	D

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4)	2. Date Exercisable and Expiration Date (Month/Day/Year)		3. Title and Amount of Securities Underlying Derivative Security (Instr. 4)		4. Conversion or Exercise Price of Derivative Security	5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Stock Option (Right to Buy)	(1)	07/01/2027	Ordinary Shares	30,939	$1.06	D
Stock Option (Right to Buy)	(1)	01/01/2028	Ordinary Shares	145,371	$1.17	D
Stock Option (Right to Buy)	(1)	06/30/2030	Ordinary Shares	432,624	$10	D
Stock Option (Right to Buy)	(2)	06/30/2030	Ordinary Shares	1,598,000	$10	D
Stock Option (Right to Buy)	(1)	12/17/2030	Ordinary Shares	168,000	$9.68	D
Stock Option (Right to Buy)	(1)	12/08/2031	Ordinary Shares	168,000	$11	D
Stock Option (Right to Buy)	(3)	06/13/2032	Ordinary Shares	135,000	$7.94	D
Stock Option (Right to Buy)	(4)	12/12/2032	Ordinary Shares	388,000	$9.75	D
Stock Option (Right to Buy)	(5)	12/04/2033	Ordinary Shares	390,000	$9.06	D
Stock Option (Right to Buy)	(6)	12/02/2034	Ordinary Shares	300,000	$8.06	D
Stock Option (Right to Buy)	(7)	01/07/2036	Ordinary Shares	753,750	$9.32	D
Restricted Stock Units	(8)	(8)	Ordinary Shares	167,500	$0	D

Explanation of Responses:

1. These options to purchase ordinary shares of the Issuer ("Ordinary Shares," and each such option, an "Option") are fully vested.

2. These Options are eligible to be earned based on the achievement of specified market capitalization performance hurdles and service-vesting conditions. The service-vesting conditions are satisfied as to 25% of the Options on the first anniversary of the grant date, June 30, 2020, and 6.25% of the Options on each quarterly anniversary of such date over the following three years.

3. These Options vest 25% on the first anniversary of the grant date, June 14, 2022, then in 12 equal quarterly installments over the following three years.

4. These Options vest 25% on the first anniversary of the grant date, December 13, 2022, then in 12 equal quarterly installments over the following three years.

5. These Options vest 25% on the first anniversary of the grant date, December 5, 2023, then in 12 equal quarterly installments over the following three years.

6. These Options vest 25% on the first anniversary of the grant date, December 3, 2024, then in 12 equal quarterly installments over the following three years.

7. These Options vest 25% on the first anniversary of the grant date, January 8, 2026, then in 12 equal quarterly installments over the following three years.

8. Each restricted stock unit ("RSU") represents a contingent right to receive one Ordinary Share. These RSUs vest in four equal annual installments on each anniversary of the grant date, January 8, 2026.

Remarks:

Exhibit List - Exhibit 24.1 - Power of Attorney

	/s/ Edward Sturchio, attorney-in-fact for Harpreet Singh Jasuja	03/18/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 3: SEC 1473 (03-26)

FAQ

What does the Form 3 filing by Immatics IMTX CEO report?

The Form 3 reports Harpreet Singh Jasuja’s initial ownership in Immatics N.V.. It lists his direct holdings of ordinary shares, multiple stock option grants over ordinary shares, and restricted stock units that convert into ordinary shares as vesting conditions are met.

How many Immatics IMTX ordinary shares does the CEO directly hold?

Harpreet Singh Jasuja directly holds 217,241 ordinary shares of Immatics N.V. This position is reported as part of his initial beneficial ownership statement and sits alongside his various option grants and restricted stock unit awards over additional ordinary shares.

What stock options over Immatics IMTX shares are disclosed for the CEO?

The filing lists several stock options over Immatics ordinary shares with exercise prices from $1.06 to $11.00. These options have different expiration dates between 2027 and 2036 and represent rights to buy ordinary shares if exercised.

What restricted stock units (RSUs) are reported for the Immatics IMTX CEO?

The Form 3 shows 167,500 restricted stock units, each representing a contingent right to receive one ordinary share. According to the footnotes, these RSUs vest in four equal annual installments on each anniversary of the grant date, January 8, 2026.

How do the Immatics IMTX CEO’s options vest according to the filing?

Footnotes explain that certain options are fully vested, while others vest 25% on the first anniversary of their grant date and then in equal quarterly installments over the following three years, combining service-based and, for some grants, market capitalization performance conditions.

Does the Immatics IMTX Form 3 show any CEO share purchases or sales?

The data provided reflects holding entries only, with no buy or sell transactions flagged. It is an initial beneficial ownership report, detailing existing positions in ordinary shares, options and restricted stock units rather than new market trades.